Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | Options Exercise | $156K | +917 | +25.01% | $170.60 | 4.58K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$41.3K | -242 | -5.28% | $170.60 | 4.34K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $132K | +775 | +17.85% | $170.60 | 5.12K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$32.2K | -189 | -3.69% | $170.60 | 4.93K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $136K | +799 | +16.22% | $170.60 | 5.73K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$33.3K | -195 | -3.41% | $170.60 | 5.53K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $56K | +328 | +5.93% | $170.60 | 5.86K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$13.6K | -80 | -1.37% | $170.60 | 5.78K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $572K | +3.35K | +57.99% | $170.60 | 9.13K | Mar 1, 2022 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$200K | -1.17K | -12.81% | $170.60 | 7.96K | Mar 1, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2018 MSU Award | Options Exercise | $0 | -917 | -100% | $0.00* | 0 | Mar 1, 2022 | Common Stock | 917 | $0.00 | Direct | F1 |
transaction | AVY | 2019 MSU Award | Options Exercise | $0 | -775 | -67.8% | $0.00 | 368 | Mar 1, 2022 | Common Stock | 775 | $0.00 | Direct | F2 |
transaction | AVY | 2020 MSU Award | Options Exercise | $0 | -799 | -48.57% | $0.00 | 846 | Mar 1, 2022 | Common Stock | 799 | $0.00 | Direct | F3 |
transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -328 | -31.21% | $0.00 | 723 | Mar 1, 2022 | Common Stock | 328 | $0.00 | Direct | F4 |
transaction | AVY | 2019 PU Award | Options Exercise | $0 | -3.35K | -100% | $0.00* | 0 | Mar 1, 2022 | Common Stock | 3.35K | $0.00 | Direct | F5 |
transaction | AVY | 2022 MSU Award | Award | $0 | +1.5K | $0.00 | 1.5K | Mar 1, 2022 | Common Stock | 1.5K | $0.00 | Direct | F6 | |
transaction | AVY | 2022 PU Award | Award | $0 | +1.21K | $0.00 | 1.21K | Mar 1, 2022 | Common Stock | 1.21K | $0.00 | Direct | F7 |
Id | Content |
---|---|
F1 | Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2018 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2018-2021 performance period, plus dividend equivalents accrued during the period. |
F2 | Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2021 performance period, plus dividend equivalents accrued during the period. |
F3 | Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2020 at 183% of target based on our absolute total stockholder return in excess of 10% during the 2020-2021 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2021 at 135% of target based on our absolute total stockholder return in excess of 10% during the 2021 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of performance units granted in February 2019 at 188% of target, based 50% on our cumulative economic value added and 50% on our relative stockholder return. |
F6 | Market-leveraged stock units vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return, plus dividend equivalents accrued during the vesting period. Each market-leveraged stock unit represents a contingent right to receive one share of our common stock, plus dividend equivalents. |
F7 | Performance units vest, if at all, at the end of fiscal year 2024, provided the designated performance objectives are met as determined by the Compensation Committee in February 2025. Each performance unit represents a contingent right to receive one share of our common stock. |